271 related articles for article (PubMed ID: 34019671)
1. The Role of HIF1α-PFKFB3 Pathway in Diabetic Retinopathy.
Min J; Zeng T; Roux M; Lazar D; Chen L; Tudzarova S
J Clin Endocrinol Metab; 2021 Aug; 106(9):2505-2519. PubMed ID: 34019671
[TBL] [Abstract][Full Text] [Related]
2. Endothelial PFKFB3 plays a critical role in angiogenesis.
Xu Y; An X; Guo X; Habtetsion TG; Wang Y; Xu X; Kandala S; Li Q; Li H; Zhang C; Caldwell RB; Fulton DJ; Su Y; Hoda MN; Zhou G; Wu C; Huo Y
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1231-9. PubMed ID: 24700124
[TBL] [Abstract][Full Text] [Related]
3. IL1R2 promotes retinal angiogenesis to participate in retinopathy of prematurity by activating the HIF1α/PFKFB3 pathway.
Zhou N; Liu L; Li Q
Exp Eye Res; 2024 Feb; 239():109750. PubMed ID: 38097102
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
[TBL] [Abstract][Full Text] [Related]
5. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis.
Feng Y; Zou R; Zhang X; Shen M; Chen X; Wang J; Niu W; Yuan Y; Yuan F
Angiogenesis; 2021 Aug; 24(3):489-504. PubMed ID: 33400016
[TBL] [Abstract][Full Text] [Related]
6. PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies.
Liu P; Sun D; Zhang S; Chen S; Wang X; Li H; Wei F
Cell Biosci; 2024 Feb; 14(1):21. PubMed ID: 38341583
[TBL] [Abstract][Full Text] [Related]
7. The HIF1α-PFKFB3 Pathway: A Key Player in Diabetic Retinopathy.
Vezza T; Víctor VM
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4778-e4780. PubMed ID: 34171101
[No Abstract] [Full Text] [Related]
8. Activation of the HIF1α/PFKFB3 stress response pathway in beta cells in type 1 diabetes.
Nomoto H; Pei L; Montemurro C; Rosenberger M; Furterer A; Coppola G; Nadel B; Pellegrini M; Gurlo T; Butler PC; Tudzarova S
Diabetologia; 2020 Jan; 63(1):149-161. PubMed ID: 31720731
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell PHD2-HIF1α-PFKFB3 contributes to right ventricle vascular adaptation in pulmonary hypertension.
Kassa B; Kumar R; Mickael C; Sanders L; Vohwinkel C; Lee MH; Gu S; Poth JM; Stenmark KR; Zhao YY; Tuder RM; Graham BB
Am J Physiol Lung Cell Mol Physiol; 2021 Oct; 321(4):L675-L685. PubMed ID: 34346780
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of histone deacetylase SIRT1 exerts an antiangiogenic role in diabetic retinopathy via miR-20a elevation and YAP/HIF1α/VEGFA depletion.
Pan Q; Gao Z; Zhu C; Peng Z; Song M; Li L
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E932-E943. PubMed ID: 32776826
[TBL] [Abstract][Full Text] [Related]
11. Amylin deposition activates HIF1α and 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 3 (PFKFB3) signaling in failing hearts of non-human primates.
Liu M; Li N; Qu C; Gao Y; Wu L; Hu LG
Commun Biol; 2021 Feb; 4(1):188. PubMed ID: 33580152
[TBL] [Abstract][Full Text] [Related]
12. Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.
Huang H; He J; Johnson D; Wei Y; Liu Y; Wang S; Lutty GA; Duh EJ; Semba RD
Diabetes; 2015 Jan; 64(1):200-12. PubMed ID: 25187372
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
14. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
[TBL] [Abstract][Full Text] [Related]
15. p75NTR and Its Ligand ProNGF Activate Paracrine Mechanisms Etiological to the Vascular, Inflammatory, and Neurodegenerative Pathologies of Diabetic Retinopathy.
Barcelona PF; Sitaras N; Galan A; Esquiva G; Jmaeff S; Jian Y; Sarunic MV; Cuenca N; Sapieha P; Saragovi HU
J Neurosci; 2016 Aug; 36(34):8826-41. PubMed ID: 27559166
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-mediated retinal neovascularization and vascular leakage in diabetic retina is suppressed by HIF-1α destabilization by SH-1242 and SH-1280, novel hsp90 inhibitors.
Jo DH; An H; Chang DJ; Baek YY; Cho CS; Jun HO; Park SJ; Kim JH; Lee HY; Kim KW; Lee J; Park HJ; Kim YM; Suh YG; Kim JH
J Mol Med (Berl); 2014 Oct; 92(10):1083-92. PubMed ID: 24875598
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy.
Li HY; Yuan Y; Fu YH; Wang Y; Gao XY
Pharmacol Res; 2020 Sep; 159():104924. PubMed ID: 32464323
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.
Abcouwer SF; Gardner TW
Ann N Y Acad Sci; 2014 Apr; 1311():174-90. PubMed ID: 24673341
[TBL] [Abstract][Full Text] [Related]
19. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase Suppresses Neuronal Apoptosis by Increasing Glycolysis and "cyclin-dependent kinase 1-Mediated Phosphorylation of p27 After Traumatic Spinal Cord Injury in Rats.
Gao L; Wang C; Qin B; Li T; Xu W; Lenahan C; Ying G; Li J; Zhao T; Zhu Y; Chen G
Cell Transplant; 2020; 29():963689720950226. PubMed ID: 32841050
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid ameliorates diabetes-induced proliferative retinopathy through inhibition of the HIF-1α/VEGF expression via targeting PI3K/AKT pathway.
Cui J; Gong R; Hu S; Cai L; Chen L
Life Sci; 2018 Jan; 192():293-303. PubMed ID: 29129773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
